Home
About ANC
Patient Care
Patient Information
Diagnostic Tests
Procedures
Our Physician
How to find us
Interesting Links
Neurology News
Contact us
      


MEDICAL SPECIALTY

    ·     Neurology

    ·     Electrodiagnostics

    ·     Pain Management


BOARD CERTIFICATION

·     American Board of Psychiatry and Neurology (ABPN), 1999

·     American Board of Electrodiagnostic Medicine (ABEM), 2003


HOSPITAL AFFILIATIONS

·     Mission Hospital Regional Medical Center, Mission Viejo, CA


MEDICAL LEGAL EXPERTISE

·     Qualified Medical Evaluator (QME), State of California

·     Agreed Medical Examiner (AME)


EDUCATION / TRAINING

    Chief Resident, Department of Neurology LAC/USC Medical Center 1996-1997

    Residency - Neurology, LAC / USC Medical Center, Los Angeles,
1994 - 1997
 
     Internship - Internal Medicine, LAC / USC Medical Center, 1993 - 1994

     Internship/Residency - Internal Medicine, Vilnius Regional Medical Center,     
     Lithuania, 1985 - 1988

     Medical School, Kaunas Medial Academy, Lithuania, 1979 - 1985


ACADEMIC EXPERIENCE

Charles R.Drew University of Medicine and Science, Department of
Neuroscience, Chief of  Neurophysiology, 2000-2002

Charles R.Drew University of Medicine and Science, Department of Neuroscience, Assistant Clinical Professor 1999-2002

University of Southern California, Los Angeles, Department of Neurology, Volunteer Attending, 1997-2003

University of California, Irvine, Department of Neurology, Research 1992-1993


PROFESSIONAL MEMBERSHIPS

Active Member of the American Academy of Neurology (AAN)

Fellow of the American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM)

Orange County Neurological Society


PUBLICATIONS:

G.Y. Chang M.D., E. Spokoyny M.D.: Unexpected Recovery from Coma
and Electrographic Status Epilepticus. Neurology 1996, vol. 47, p.861

G.Y. Chang M.D., E. Spokoyny M.D.: Hyperkinetic Motor Behavior
in Bihemispheric Stroke. European Neurology 1996, vol. 36, # 4, p.247 

P. Sandroni  M.D., H. Michalewski Ph.D., E. Spokoyny M.D., A. Starr M.D.: Readiness Potential and "Fatigue" in Multiple Sclerosis. Presented at the American Neurological Association Meeting, 1993


TEACHING COURSES:

Headaches, Evaluation and Treatment, Charles R. Drew University,  2000-2002

Introduction to Neurological Examination, Charles R. Drew University, 1999 - 2002              

Neurological Assessment of Patients with Cranial Neuropathies, USC School of Medicine, 1996-1997


RESEARCH EXPERIENCE:  

Protocol B7A-MC-MBBR. Double Blind Multicenter Study of Treatment of Symptomatic Diabetic Peripheral Neuropathy. El Lilly. Role: Investigator

 

Protocol B7A-MC-MBBP. Double Blind Multicenter Study of Treatment of Diabetic Peripheral Neuropathy. El Lilly. Role: Investigator.

Protocol  SP754, SCHWARZ. A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Trial to Investigate the Efficacy and Safety of SPM 927 as Adjunctive Therapy in Subjects with Partial Seizures. Role: Principal Investigator.
 
Protocol LAM 40112. GSK, Double Blind Randomized Trial of Cognitive Effects of Lamictal Versus Topiramate in Epilepsy. Role: Principal Investigator.
 
Protocol LAM 40117. GSK, Efficacy of Lamictal as a Monotherapy for Partial Seizures and Co-Morbid Depression. Role: Principal Investigator.

Protocol SCAA4005. A Phase III Lamictal as a Monotherapy for Epilepsy. GlaxoWellcome. Role: Principal Investigator

Protocol 31-98-213. An Open Label Comparison of the Neurocognitive Effects of Aripiprazole to Olanzapine Administered Orally in Patients with Stable Psychosis. Otsuka America. Role:  Investigator

Protocol 31-98-215. A Phase III Open Label Treatment Switching Study from Orally Administered Antipsychotic Monotherapy to Orally Administered Aripiprazole Monotherapy in the Treatment of Chronic Schizophrenia and Schizoaffective Patients. Otsuka America. Role: Investigator 
 
Protocol: Safety and Efficacy of Tiagabine HCL as Adjunctive Treatment of Epilepsy. Abbot Laboratories. Role: Principal Investigator

Protocol 31. A Multicenter, Double-Blind, Active-Control Evaluation of a Monotherapy Drug in Patients with Partial Seizures. Burroughs-Wellcome, Inc. Role:  Principal Investigator.

Protocol: A Prospective, Randomized, Double Blind, Placebo-and Active-Controlled, Multi-Center Study to Evaluate the Efficacy and Safety of Three Fixed Doses of Iloperidone Given B.I.D. for 42 Days to Schizophrenic Patients with Acute or Sub Acute Exacerbation, Followed by a Double-Blind, Active-Controlled, Flexible-Dose, Long-Term, 6-Month Phase with Iloperidone Given Q.D. Novartis Pharmaceuticals.  Role: Investigator

Protocol M97-696.  Evaluation of the Efficacy and Safety of Depakote Cr in the Treatment of the Manic Phase of Bipolar Disorder: A Placebo Controlled Study.  Abbott Laboratories. Role: Investigator

Protocol FID-MC-HGGN. The Comparative Efficacy of Olanzapine, Risperdone and Haloperidol for Cognition in Schizophrenia and Schizoaffective Disorder.  Eli Lilly. Role:  Investigator

Protocol SCAA2008.  A Multi-Center, Double-Blind, Placebo-Controlled, Evaluation of the Safety and Efficacy of Lamictal Compared to Placebo and Lithium in the Treatment of an Acute Manic or Mixed Episode in Patients Who Have Bipolar Disorder.  GlaxoWellcome.  Role: Investigator


LECTURES/PRESENTATIONS:


Anti-Platelets for the Prevention of Secondary Ischemic Stroke, 2005, Mission Hospital Regional Center
 
Teleconference: Aggrenox Prevention of Secondary Ischemic Stroke., 2004
 
Teleconference: Overview of Aggrenox: ESPS2 and PROFESS, 2004

Teleconference: Antiplatelet Therapy for the Secondary Prevention of Stroke, 2004

Spasticity, Diagnosis and Management. 2002, Charles R. Drew University.

Neuropathic Pain. 2000, Charles R. Drew University.
 
Radiculopathy, Sensitivity and Specificity of EMG and MRI. 1999, Charles R. Drew University
 
Headaches: New Treatment Modalities. 1999, Charles R. Drew University

Acute Demyelinating Encephalomyelitis 1999, Charles R. Drew University 

Primary Central Nervous System Vasculitis. 1998, Charles R. Drew University
 
Cerebellar Ataxia, Diagnostic Dilemma, 1997, LAC-USC Medical Center
 
Drug Resistant Pneumococcal Meningitis, New Therapeutic Strategies,1997, LAC-USC Medical Center
 
Neuropathological Characteristics of the PSP, 1997, LAC-USC Medical Center

Peduncular Hallucinosis, Anatomical Correlates, 1996, LAC-USC Medical Center
 
Clinico-Pathological Characteristics of Head Trauma in Children, 1996, Children Hospital of LA
 
West Syndrome, 1996,Children Hospital of LA
 
Echinococcosis in the CNS,1996 LAC-USC Medical Center
 
Eclampsia, Complications and Management. 1995, LAC-USC Medical Center 
 

     AFFILIATED NEUROLOGY CENTER
    25982 Pala, Suite 150
    Mission Viejo, CA 92691
    Tel: (949) 586-5500


 
   
   
   
Top